SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma

Table 2

Univariate analysis of clinicopathological features for overall survival of patients with intrahepatic cholangiocarcinoma.

Characteristics ()	Number	Survival rate (%)	^∗
Gender			0.064
Female	31	32.3
Male	69	34.8
Age (years)			0.325
<60	52	38.5
≥60	48	29.2
SHMT2 expression			0.030
Low	48	45.8
High	52	23.1
Vascular invasion			0.470
No	64	31.3
Yes	36	38.9
Tumor number			0.012
Solitary	91	35.2
Multiple	9	22.2
Tumor size (cm)			0.484
≤5	40	32.5
>5	60	35.0
Pathological grade			0.800
I	4	50
II	62	33.9
III	34	32.4
T stage			<0.001
T1	42	40.5
T2	47	34.0
T3–T4	11	9.0
N stage			0.888
N0	86	33.7
N1	14	35.7
Metastasis			0.073
No	96	35.4
Yes	4	0
TNM stage			0.058
I	34	38.2
II	42	35.7
III–IV	24	25.0